*November 2019*
Jill Feldman, an EGFR Resisters co-founder was interviewed on the Today Show regarding Lung Cancer Awareness Month. Watch it here.
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.